Related Experiment Video
Updated: Jul 17, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Weight loss as a treatment for obstructive sleep apnoea
V A Barvaux1, G Aubert, D O Rodenstein
1Pneumology Unit, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels 1200, Belgium.
Sleep Medicine Reviews
|January 11, 2007
Summary
Obesity is a significant health issue linked to obstructive sleep apnoea (OSA). While weight loss aids OSA treatment, it rarely cures it alone, often requiring complementary therapies like nasal continuous positive airway pressure (nCPAP).
Area of Science:
- Medical Science
- Public Health
Background:
- Obesity is a prevalent health concern in developed nations.
- It is associated with numerous metabolic, cardiovascular, and psychological conditions.
- Obesity is a known risk factor for obstructive sleep apnoea (OSA).
Purpose of the Study:
- To review the relationship between obesity and OSA.
- To examine conservative and surgical obesity treatments.
- To evaluate weight loss effectiveness in managing OSA.
Main Methods:
- Literature review on obesity and OSA.
- Analysis of obesity treatment modalities.
- Assessment of weight loss impact on OSA management.
Main Results:
- Weight loss is a crucial factor in managing OSA.
- Weight loss alone infrequently resolves OSA.
- Combination therapy, including nCPAP, is often necessary for OSA treatment.
Conclusions:
- Weight loss is important for facilitating OSA treatment.
- Complete resolution of OSA through weight loss alone is rare.
- Integrated treatment approaches combining weight loss with standard therapies like nCPAP are most effective.
Related Concept Videos
01:21Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...